|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 650 for Ptpn11

<< First    < Previous  |  Next >    Last >>
0.04s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
Type: gene
Organism: Not Specified
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: chimpanzee
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: chicken
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: frog, western clawed
Gene
Type: gene
Organism: rat
Gene
Type: gene
Organism: dog, domestic
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: human
Publication
First Author: Usenko T
Year: 2014
Journal: PLoS One
Title: Leukemogenic Ptpn11 allele causes defective erythropoiesis in mice.
Volume: 9
Issue: 10
Pages: e109682
Publication    
First Author: Griger J
Year: 2017
Journal: Elife
Title: Loss of Ptpn11 (Shp2) drives satellite cells into quiescence.
Volume: 6
Publication
First Author: Yang Z
Year: 2008
Journal: Exp Hematol
Title: Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival.
Volume: 36
Issue: 10
Pages: 1285-96
Publication
First Author: Schramm C
Year: 2012
Journal: Am J Physiol Heart Circ Physiol
Title: The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.
Volume: 302
Issue: 1
Pages: H231-43
Publication
First Author: Chan G
Year: 2011
Journal: Blood
Title: Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.
Volume: 117
Issue: 16
Pages: 4253-61
Publication
First Author: Dong L
Year: 2016
Journal: Nature
Title: Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
Volume: 539
Issue: 7628
Pages: 304-308
Publication
First Author: Yang W
Year: 2013
Journal: Nature
Title: Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling.
Volume: 499
Issue: 7459
Pages: 491-5
Publication
First Author: Liu X
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Gain-of-function mutations of Ptpn11 (Shp2) cause aberrant mitosis and increase susceptibility to DNA damage-induced malignancies.
Volume: 113
Issue: 4
Pages: 984-9
Publication
First Author: Chan G
Year: 2009
Journal: Blood
Title: Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.
Volume: 113
Issue: 18
Pages: 4414-24
Publication
First Author: Marin TM
Year: 2011
Journal: J Clin Invest
Title: Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.
Volume: 121
Issue: 3
Pages: 1026-43
Publication
First Author: Ventura PMO
Year: 2022
Journal: EMBO Rep
Title: Concomitant deletion of Ptpn6 and Ptpn11 in T cells fails to improve anticancer responses.
Volume: 23
Issue: 11
Pages: e55399
Publication
First Author: Araki T
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation.
Volume: 106
Issue: 12
Pages: 4736-41
Publication
First Author: Liu W
Year: 2017
Journal: Leukemia
Title: Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations.
Volume: 31
Issue: 6
Pages: 1415-1422
Publication
First Author: Xu D
Year: 2013
Journal: PLoS One
Title: Activating mutations in protein tyrosine phosphatase Ptpn11 (Shp2) enhance reactive oxygen species production that contributes to myeloproliferative disorder.
Volume: 8
Issue: 5
Pages: e63152
Publication
First Author: Araki T
Year: 2004
Journal: Nat Med
Title: Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.
Volume: 10
Issue: 8
Pages: 849-57
Publication
First Author: Zhang W
Year: 2009
Journal: J Biol Chem
Title: Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia.
Volume: 284
Issue: 33
Pages: 22353-63
Publication
First Author: Chen L
Year: 2015
Journal: Leukemia
Title: Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.
Volume: 29
Issue: 6
Pages: 1290-300
Publication
First Author: Xu D
Year: 2010
Journal: Blood
Title: A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells.
Volume: 116
Issue: 18
Pages: 3611-21
Publication
First Author: Xu D
Year: 2011
Journal: J Exp Med
Title: Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells.
Volume: 208
Issue: 10
Pages: 1977-88
Publication
First Author: Yang Z
Year: 2009
Journal: Mol Cell Biol
Title: Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants.
Volume: 29
Issue: 16
Pages: 4376-93
Publication
First Author: Zheng H
Year: 2013
Journal: J Biol Chem
Title: Induction of a tumor-associated activating mutation in protein tyrosine phosphatase Ptpn11 (Shp2) enhances mitochondrial metabolism, leading to oxidative stress and senescence.
Volume: 288
Issue: 36
Pages: 25727-38
Publication
First Author: Tarnawsky SP
Year: 2017
Journal: Dev Dyn
Title: Yolk sac erythromyeloid progenitors expressing gain of function PTPN11 have functional features of JMML but are not sufficient to cause disease in mice.
Volume: 246
Issue: 12
Pages: 1001-1014
Publication
First Author: Kontaridis MI
Year: 2008
Journal: Circulation
Title: Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways.
Volume: 117
Issue: 11
Pages: 1423-35
Publication
First Author: Hill KS
Year: 2019
Journal: Mol Cancer Res
Title: PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas.
Volume: 17
Issue: 2
Pages: 583-593
Protein
Organism: Mus musculus/domesticus
Length: 276  
Fragment?: true
Publication
First Author: Paardekooper Overman J
Year: 2014
Journal: Mol Cell Biol
Title: PZR coordinates Shp2 Noonan and LEOPARD syndrome signaling in zebrafish and mice.
Volume: 34
Issue: 15
Pages: 2874-89
Publication
First Author: Edwards MA
Year: 2015
Journal: J Appl Physiol (1985)
Title: The Q510E mutation in Shp2 perturbs heart valve development by increasing cell migration.
Volume: 118
Issue: 1
Pages: 124-31
Publication
First Author: Zhao H
Year: 2019
Journal: Oncogene
Title: Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis.
Volume: 38
Issue: 13
Pages: 2275-2290
Publication
First Author: Yi JS
Year: 2016
Journal: JCI Insight
Title: Low-dose dasatinib rescues cardiac function in Noonan syndrome.
Volume: 1
Issue: 20
Pages: e90220
Publication
First Author: Bellio M
Year: 2019
Journal: Blood
Title: Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions.
Volume: 134
Issue: 25
Pages: 2304-2317
Publication
First Author: Li XJ
Year: 2015
Journal: J Biol Chem
Title: Protein-tyrosine phosphatase Shp2 positively regulates macrophage oxidative burst.
Volume: 290
Issue: 7
Pages: 3894-909
Publication
First Author: Lapinski PE
Year: 2013
Journal: Dis Model Mech
Title: Deletion of SHP-2 in mesenchymal stem cells causes growth retardation, limb and chest deformity, and calvarial defects in mice.
Volume: 6
Issue: 6
Pages: 1448-58
Publication
First Author: Coulombe G
Year: 2013
Journal: Mol Cell Biol
Title: Epithelial tyrosine phosphatase SHP-2 protects against intestinal inflammation in mice.
Volume: 33
Issue: 11
Pages: 2275-84
Publication
First Author: Gu S
Year: 2018
Journal: Leukemia
Title: SHP2 is required for BCR-ABL1-induced hematologic neoplasia.
Volume: 32
Issue: 1
Pages: 203-213
Publication
First Author: Gagné-Sansfaçon J
Year: 2016
Journal: Oncotarget
Title: SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development.
Volume: 7
Issue: 40
Pages: 65676-65695
Publication
First Author: Tarnawsky SP
Year: 2018
Journal: Oncotarget
Title: Hematopoietic-restricted Ptpn11E76K reveals indolent MPN progression in mice.
Volume: 9
Issue: 31
Pages: 21831-21843
Publication
First Author: Liu X
Year: 2012
Journal: Cancer Res
Title: Protein tyrosine phosphatase Shp2 (Ptpn11) plays an important role in maintenance of chromosome stability.
Volume: 72
Issue: 20
Pages: 5296-306
Publication
First Author: Nakamura T
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Protein tyrosine phosphatase activity in the neural crest is essential for normal heart and skull development.
Volume: 106
Issue: 27
Pages: 11270-5
Publication  
First Author: Yi JS
Year: 2020
Journal: JCI Insight
Title: Tyrosyl phosphorylation of PZR promotes hypertrophic cardiomyopathy in PTPN11-associated Noonan syndrome with multiple lentigines.
Volume: 5
Issue: 15
Publication
First Author: Bowen ME
Year: 2014
Journal: PLoS Genet
Title: SHP2 regulates chondrocyte terminal differentiation, growth plate architecture and skeletal cell fates.
Volume: 10
Issue: 5
Pages: e1004364
Publication      
First Author: Yi JS
Year: 2021
Journal: Cardiovasc Drugs Ther
Title: Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.
Publication
First Author: Wang J
Year: 2017
Journal: PLoS One
Title: In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy.
Volume: 12
Issue: 6
Pages: e0178905
Publication
First Author: Tajan M
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity.
Volume: 111
Issue: 42
Pages: E4494-503
Publication  
First Author: Zuo C
Year: 2018
Journal: Bone Res
Title: SHP2 regulates skeletal cell fate by modifying SOX9 expression and transcriptional activity.
Volume: 6
Pages: 12
Publication  
First Author: Zheng H
Year: 2018
Journal: Sci Signal
Title: Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner.
Volume: 11
Issue: 522
Publication
First Author: Deng L
Year: 2018
Journal: Oncotarget
Title: Rapid development of myeloproliferative neoplasm in mice with Ptpn11D61Y mutation and haploinsufficient for Dnmt3a.
Volume: 9
Issue: 5
Pages: 6055-6061
Publication
First Author: Saxton TM
Year: 2000
Journal: Nat Genet
Title: The SH2 tyrosine phosphatase shp2 is required for mammalian limb development.
Volume: 24
Issue: 4
Pages: 420-3
Publication
First Author: Altmüller F
Year: 2017
Journal: PLoS Genet
Title: Aberrant neuronal activity-induced signaling and gene expression in a mouse model of RASopathy.
Volume: 13
Issue: 3
Pages: e1006684
Publication
First Author: Wang L
Year: 2021
Journal: FASEB J
Title: SHP2 regulates the development of intestinal epithelium by modifying OSTERIX+ crypt stem cell self-renewal and proliferation.
Volume: 35
Issue: 1
Pages: e21106
Publication
First Author: Wang L
Year: 2018
Journal: FASEB J
Title: A ERK/RSK-mediated negative feedback loop regulates M-CSF-evoked PI3K/AKT activation in macrophages.
Volume: 32
Issue: 2
Pages: 875-887
Publication
First Author: De Rocca Serra-Nédélec A
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature.
Volume: 109
Issue: 11
Pages: 4257-62
Publication
First Author: Chen B
Year: 2000
Journal: Nat Genet
Title: Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis.
Volume: 24
Issue: 3
Pages: 296-9
Publication
First Author: Ehrman LA
Year: 2014
Journal: J Neurosci
Title: The protein tyrosine phosphatase Shp2 is required for the generation of oligodendrocyte progenitor cells and myelination in the mouse telencephalon.
Volume: 34
Issue: 10
Pages: 3767-78
Publication
First Author: Ruess DA
Year: 2018
Journal: Nat Med
Title: Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase.
Volume: 24
Issue: 7
Pages: 954-960
Publication
First Author: Tebbutt NC
Year: 2002
Journal: Nat Med
Title: Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice.
Volume: 8
Issue: 10
Pages: 1089-97
Publication  
First Author: Gong H
Year: 2019
Journal: J Mol Cell Cardiol
Title: Shp2 in myocytes is essential for cardiovascular and neointima development.
Volume: 137
Pages: 71-81
Publication
First Author: Li K
Year: 2014
Journal: J Neurosci
Title: Shp2-dependent ERK signaling is essential for induction of Bergmann glia and foliation of the cerebellum.
Volume: 34
Issue: 3
Pages: 922-31
Publication
First Author: Krenz M
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome.
Volume: 105
Issue: 48
Pages: 18930-5
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Ai J
Year: 2006
Journal: Blood
Title: The inositol phosphatase SHIP-2 down-regulates FcgammaR-mediated phagocytosis in murine macrophages independently of SHIP-1.
Volume: 107
Issue: 2
Pages: 813-20
Publication
First Author: Salmond RJ
Year: 2005
Journal: J Immunol
Title: The src homology 2 domain-containing tyrosine phosphatase 2 regulates primary T-dependent immune responses and Th cell differentiation.
Volume: 175
Issue: 10
Pages: 6498-508
Publication
First Author: Fornaro M
Year: 2006
Journal: J Cell Biol
Title: SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth.
Volume: 175
Issue: 1
Pages: 87-97
Publication
First Author: Verma R
Year: 2015
Journal: Mol Cell Biol
Title: Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury.
Volume: 36
Issue: 4
Pages: 596-614
Publication
First Author: Lee YS
Year: 2014
Journal: Nat Neurosci
Title: Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome.
Volume: 17
Issue: 12
Pages: 1736-43
Publication
First Author: Wang S
Year: 2009
Journal: J Biol Chem
Title: Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis.
Volume: 284
Issue: 2
Pages: 913-20
Publication  
First Author: Paccoud R
Year: 2021
Journal: Sci Transl Med
Title: SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations.
Volume: 13
Issue: 591
Publication
First Author: Levy AD
Year: 2018
Journal: Cell Rep
Title: Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function.
Volume: 24
Issue: 6
Pages: 1523-1535